0001144204-19-000617.txt : 20190104 0001144204-19-000617.hdr.sgml : 20190104 20190104144043 ACCESSION NUMBER: 0001144204-19-000617 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Celsion CORP CENTRAL INDEX KEY: 0000749647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521256615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-37826 FILM NUMBER: 19509519 BUSINESS ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 BUSINESS PHONE: (609) 896-9100 MAIL ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 FORMER COMPANY: FORMER CONFORMED NAME: CELSION CORP DATE OF NAME CHANGE: 19980515 FORMER COMPANY: FORMER CONFORMED NAME: CHEUNG LABORATORIES INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EGWU, Inc. fka EGEN, Inc. CENTRAL INDEX KEY: 0001558526 IRS NUMBER: 870609894 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 3400 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: 2563270566 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 3400 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: EGEN, Inc. DATE OF NAME CHANGE: 20120919 SC 13G/A 1 tv510415_sc13ga.htm SC 13G/A

 

 

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 4)

 

Celsion Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

15117N404

(CUSIP Number)

 

December 31, 2017

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨Rule 13d-1(b)
xRule 13d-1(c)
¨Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

SCHEDULE 13G

 

CUSIP No. 15117N404    

 

 

         
1.   NAMES OF REPORTING PERSONS

EGWU, Inc., formerly known as Egen, Inc. 1
   
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)     ¨
(b)     ¨
   
3.   SEC USE ONLY
 
   
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
 
State of Alabama
   

NUMBER OF

  5.   SOLE VOTING POWER
 
212,816
SHARES

BENEFICIALLY

OWNED BY

  6.   SHARED VOTING POWER
 
NONE
EACH
REPORTING
PERSON
  7.   SOLE DISPOSITIVE POWER
 
212,816
WITH   8.   SHARED DISPOSITIVE POWER
 
NONE
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

212,816
   
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
   
         
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

1.20%2
   
12.   TYPE OF REPORTING PERSON (see instructions)

CO
   
                             

 

 

1 The shares were originally issued in the name of Egen, Inc. and Egen, Inc. subsequently changed its corporate name to EGWU, Inc.

2 Based on the information set forth in the Quarterly Report on Form 10-Q of Celsion Corporation (“Issuer”) filed with the Securities and Exchange Commission on November 14, 2018, there were 17,911,120 shares of Issuer’s common stock, par value $0.01 per share (the “Common Stock”) outstanding as of September 30, 2018. This Amendment No. 4 constitutes an exit filing for the Reporting Person as the Reporting Person beneficially owns less than 5% of the Common Stock of Issuer.

 

Page 2 of 6

 

 

Item 1.

 

 

(a) Name of Issuer:
     
    Celsion Corporation
     
  (b)

Address of Issuer’s Principal Executive Offices

     
   

997 Lenox Drive, Suite 11

Lawrenceville, NJ 08648

 

Item 2.

 

 

(a) Name of Person Filing:
     
    EGWU, Inc., formerly known as Egen, Inc. 3
     
  (b)

Address of the Principal Office or, if None, Residence:

     
   

601 Genome Way

Suite 2001

Huntsville, Alabama 35806

     
  (c) Citizenship:
     
    State of Alabama
     
  (d) Title of Class of Securities:
     
    Common Stock
     
  (e) CUSIP No:
     
    15117N404

 

Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act;
       
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act;
       
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act;
       
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940;
       
  (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
  (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
  (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       
  (j) ¨  A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       
  (k) ¨ Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

  

 

 

3 The shares were originally issued in the name of Egen, Inc. and Egen, Inc. subsequently changed its corporate name to EGWU, Inc.

 

Page 3 of 6

 

 

Item 4.  Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned:  212,816
     
  (b) Percent of class:  1.19%4
     
  (c) Number of shares as to which the person has:
     
    (i) Sole power to vote or to direct the vote  212,816
       
    (ii) Shared power to vote or to direct the vote  NONE
       
    (iii) Sole power to dispose or to direct the disposition of  212,816
       
    (iv) Shared power to dispose or to direct the disposition of  NONE

   

Item 5.  Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following     x .

 

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

Item 7.  Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

 

Not applicable

 

 

4 Based on the information set forth in the Quarterly Report on Form 10-Q of Celsion Corporation (“Issuer”) filed with the Securities and Exchange Commission on November 14, 2018, there were 17,911,454 shares of Issuer’s Common Stock outstanding as of November 14, 2018. This Amendment No. 4 constitutes an exit filing for the Reporting Person as the Reporting Person beneficially owns less than 5% of the Common Stock of Issuer. 

 

Page 4 of 6

 

 

Item 8.  Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9.  Notice of Dissolution of Group.

 

Not applicable

 

Item 10.  Certification.

 

Not applicable

 

Page 5 of 6

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

     
  By: /s/ J. MILTON HARRIS
    J. Milton Harris, President
     
  Dated: January 4, 2019
     

 

 

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

 

Page 6 of 6